Takeda Pharmaceutical company profile

4502 · TSE · JPY

¥6,937.00Change from previous close: +0.16%Absolute change: +¥11.00

Close · November 16, 2026

Company profile

Takeda Pharmaceutical has 47,029 employees and is headquartered in Chuo, Japan.

Nearly half of the sales of this Japanese drugmaker are generated in the United States, which accounts for 48.0% of revenue, while Europe and Canada add 25.4% and Japan 9.6%. The company researches, develops, manufactures and markets pharmaceutical products, and it also out-licenses them to other companies. Its portfolio covers gastroenterology, neuroscience and oncology, with brands such as Entyvio, Adcetris, Trintellix and Vyvanse, along with the QDENGA brand. Partnerships for development and commercialization include AbbVie, GSK, Ipsen and Novavax, and its sales reach Latin America, China, the rest of Asia, Russia and the Commonwealth of Independent States, the Middle East, Oceania and Africa.

In the fiscal year ended March 2026, revenue reached 4,505.7 billion yen, down 1.7% from the previous year, and the company posted a net loss of 152.4 billion yen. The group employs 47,029 people and is headquartered in Chuo, Japan, where it was founded in 1781. Its shares also trade on the New York Stock Exchange.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
Japan
Headquarters
1-1, Nihonbashi-Honcho 2-chome, 103-8668, Chuo
Employees
47,029
Chief executive
Julie Kim
Founded
1781
Fiscal year
April - March
Listing
4502 · TSE
Indices
Nikkei 225
Currency
JPY
ISIN
JP3463000004
Website
takeda.com

Takeda Pharmaceutical and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Takeda Pharmaceutical4502Japan$65.5B47,02916.6%253.2
Sun Pharmaceutical IndustriesSUNPHARMAIndia$47.86B47,00023.3%41.1
Jiangsu Hengrui Pharmaceuticals600276China$47.82B20,60227.4%35.9
Divi's LaboratoriesDIVISLABIndia$32.23B11,56534.0%90.6
Hansoh Pharmaceutical Group3692Hong Kong SAR China$26.6B9,64337.3%28.4
Torrent PharmaceuticalsTORNTPHARMIndia$18.85B18,25822.2%78.9

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Takeda Pharmaceutical with its competitors